$0.33
+0.05 (+18.66%)
Open$0.29
Previous Close$0.28
Day High$0.35
Day Low$0.28
52W High$3.91
52W Low$0.11
Volume—
Avg Volume1.93M
Market Cap38.55M
P/E Ratio—
EPS$-0.33
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.95M | 2.89M | 2.41M |
| Net Income | -877,894 | -779,690 | -617,534 |
| Profit Margin | -29.8% | -27.0% | -25.7% |
| EBITDA | -957,867 | -819,475 | -798,278 |
| Free Cash Flow | -748,445 | -747,364 | -598,338 |
| Rev Growth | +6.0% | +2.0% | +0.0% |
| Debt/Equity | 0.66 | 0.66 | 0.48 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $214.87 | -1.20% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $354.05 | +0.63% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $140.73 | +0.98% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $449.71 | +0.71% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $776.21 | +0.46% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $330.87 | +4.68% | 139.7 | 43.84B |